2007 Presenting Companies

Columbia Scientific
Columbia Scientific is a commercialization firm specializing in new interventions for the Neuro-rehabilitation marketplace. Columbia Scientific is dedicated to introducing new diagnostic and treatment devices for rehabilitation healthcare professionals. Currently, Columbia Scientific provides information, access to training and certification, as well as products and supplies for these "change of practice" interventions.

Intelect Medical, Inc.
Intelect Medical focuses on the development and commercialization of novel neurostimulation systems for improving the recovery of brain injury patients. The development of our Deep Brain Stimulation (DBS) system leverages the clinical and research expertise of the Center for Neurological Restoration at the Cleveland Clinic and the Laboratory for Cognitive Neuromodulation at Weill Cornell Medical College.


Electrical Geodesics, Inc.
Founded in 1992, Electrical Geodesics Inc. has developed a new generation of high-resolution EEG measurement and analysis systems for use in medicine, psychology, and neuroscience research. EGI's 128-channel system, based on patented Geodesic Sensor Net technology, has made dense sensor array recording practical and inexpensive. The firm's 256-, 128-, and 64-channel systems are now in use in research laboratories in the U.S., Europe, and Asia, in projects ranging from infant language comprehension to EEG pathology in dementia.


Synapse Biomedical Inc.
Synapse Biomedical Inc. (SBI) is established with the mission to develop, manufacture, market, and support life-changing minimally invasive neurostimulation devices used in the diagnosis and treatment of persons with neurological impairment. Founded in September 2002 to support the ongoing clinical study of the DPS System for Chronic Respiratory Insufficiency at University Hospitals of Cleveland , SBI has licensed the core patents from Case Western Reserve University and is comprised of investigators from University Hospitals, MetroHealth Medical Center, and Case Western Reserve University. The current percutaneous technology has been successful in spinal cord patients for over 50 cumulative patient years and demonstrated clinical promise in the pilot series of ALS patients. The longest implanted patient has used the device for full-time respiratory support for over six years. SBI's product portfolio is focused on neurostimulation devices for minimally invasive surgical interventions and respiratory assist.


Click here for presenting firms from previous years.